Observational studyJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2022

Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis.

Amanda L Stapleton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.